The unprecedented COVID-19 pandemic spanning over three years claimed millions of lives worldwide and caused immense misery to the humanity. Rapid developments of vaccines...
Cases of co-infections with two variants were earlier reported. Not much was known about viral recombination yielding viruses with hybrid genomes. Two recent studies report...
Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against...
Evidences so far suggest that Omicron variant of SARS-CoV-2 has high transmission rate but fortunately is low on virulence and is not usually leading...
Sotrovimab, a monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...
In order to raise levels of protection across the population against the Omicron variant, the Joint Committee on Vaccination and Immunisation (JCVI)1 of UK has...
The B.1.1.529 variant was first reported to WHO from South Africa on 24th November 2021. The first known confirmed B.1.1.529 infection was from a specimen...